Skip to main content
SpringerLink
Log in

Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Among new biological markers that could become useful prognostic factors for non-small cell lung cancer (NSCLC). Survivin is one of the most commonly over-expressed oncogenes, however, its role in NSCLC remains controversial. We performed a systematic review of the literature with meta-analysis to clarify this issue. Electronic databases were used to identify published studies before August 2011. Pooled hazard ratio (HR) with 95 % confidence interval (95 % CI) was used to estimate the strength of the association of survivin expression with survival of NSCLC patients. Heterogeneity and publication bias were also assessed. Overall 29 relevant published studies including 2,517 lung cancer patients were identified from electronic databases. We found that overexpression of survivin in NSCLC patients might be a poor prognostic factor for survival 1.95 (95 % CI: 1.65-2.29; P < 0.001). Heterogeneity testing indicated that there was heterogeneity among studies. When stratified by histology types, the heterogeneity was absent. We should point out that the publication bias may partly account for the result, but the conclusion might not be affected deeply by the publication bias. When we accounted for publication bias using the trim and fill method, the results remained significant (HR = 1.71, 95 % CI: 1.44–2.02, P < 0.001), suggesting the stability of our results. Therefore, our study suggested that survivin overexpression had a poor prognosis value in patients with NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Boyle P, Dresler C (2005) Preventing the lung cancer epidemic. Ann Oncol 16(10):1565–1566

    Article  PubMed  CAS  Google Scholar 

  2. Farjadfar A, Mojtahedi Z, Ghayumi MA et al (2009) Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta Oncol 48(7):971–976

    Article  PubMed  CAS  Google Scholar 

  3. Witschi H (2001) A short history of lung cancer. Toxicol Sci 64(1):4–6

    Article  PubMed  CAS  Google Scholar 

  4. Esposito L, Conti D, Ailavajhala R et al (2010) Lung cancer: are we up to the challenge? Curr Genomics 11(7):513–518

    Article  PubMed  CAS  Google Scholar 

  5. Vischioni B, Oudejans JJ, Vos W et al (2006) Frequent overexpression of aurora B kinase, a novel drug target, in non-small cell lung carcinoma patients. Mol Cancer Ther 5(11):2905–2913

    Article  PubMed  CAS  Google Scholar 

  6. Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of progress. Chest 122(3):1037–1057

    Article  PubMed  Google Scholar 

  7. Warnecke-Eberz U, Baldus SE, Bollschweiler E et al (2008) Up-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosis. Anticancer Res 28(3A):1525–1529

    PubMed  CAS  Google Scholar 

  8. Li F, Ambrosini G, Chu EY et al (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396(6711):580–584

    Article  PubMed  CAS  Google Scholar 

  9. Ulukus EC, Kargi HA, Sis B et al (2007) Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis. Appl Immunohistochem Mol Morphol 15(1):31–37

    Article  PubMed  CAS  Google Scholar 

  10. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3(1):46–54

    Article  PubMed  CAS  Google Scholar 

  11. Machtay M, Jeremic B (2003) Complex and controversial issues in locally advanced non-small cell lung carcinoma. Semin Surg Oncol 21(2):128–137

    Article  PubMed  Google Scholar 

  12. Adida C, Berrebi D, Peuchmaur M et al (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351(9106):882–883

    Article  PubMed  CAS  Google Scholar 

  13. Atikcan S, Unsal E, Demirag F et al (2006) Correlation between survivin expression and prognosis in non-small cell lung cancer. Respir Med 100(12):2220–2226

    Article  PubMed  Google Scholar 

  14. Xu P, Xu XL, Huang Q, et al. (2011) CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis. Med Oncol.doi: 10.1007/s12032-011-0053-3

  15. Vischioni B, van der Valk P, Span SW et al (2004) Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann Oncol 15:1654–1660

    Article  PubMed  CAS  Google Scholar 

  16. Falleni M, Pellegrini C, Marchetti A et al (2003) Survivin gene expression in early-stage non-small cell lung cancer. J Pathol 200(5):620–626

    Article  PubMed  CAS  Google Scholar 

  17. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815–2834

    Article  PubMed  CAS  Google Scholar 

  18. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  PubMed  CAS  Google Scholar 

  19. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed  CAS  Google Scholar 

  20. Lu B, Gonzalez A, Massion PP et al (2004) Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer 91(3):537–540

    Article  PubMed  CAS  Google Scholar 

  21. Yoo J, Jung JH, Lee MA et al (2007) Immunohistochemical analysis of non-small cell lung cancer: correlation with clinical parameters and prognosis. J Korean Med Sci 22(2):318–325

    Article  PubMed  Google Scholar 

  22. Zhou JM, Zhou JH, Deng ZH et al (2005) Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 30(5):544–548

    PubMed  CAS  Google Scholar 

  23. Akyürek N, Memiş L, Ekinci O et al (2006) Survivin expression in pre-invasive lesions and non-small cell lung carcinoma. Virchows Arch 449(2):164–170

    Article  PubMed  Google Scholar 

  24. Grossi F, Spizzo R, Bordo D et al (2010) Prognostic stratification of stage IIIA pN2 non-small cell lung cancer by hierarchical clustering analysis of tissue microarray immunostaining data: an Alpe Adria Thoracic Oncology Multidisciplinary Group study (ATOM 014). J Thorac Oncol 5(9):1354–1360

    Article  PubMed  Google Scholar 

  25. Fan CF, Xu HT, Lin XY et al (2011) A multiple marker analysis of apoptosis-associated protein expression in non-small cell lung cancer in a Chinese population. Folia Histochem Cytobiol 49(2):231–239

    PubMed  Google Scholar 

  26. Wang DF, Zeng CG, Lin YB et al (2006) Expression and clinical significance of apoptosis-related oncogenes in stage I-II non-small cell lung cancer. Ai Zheng 25(3):359–362

    PubMed  CAS  Google Scholar 

  27. Yang DX, Li NE, Ma Y et al (2010) Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density. Chin J Cancer 29(4):396–402

    Article  PubMed  Google Scholar 

  28. Mohamed S, Yasufuku K, Nakajima T et al (2009) Nuclear survivin in pN2 nonsmall cell lung cancer: prognostic and clinical implications. Eur Respir J 33(1):127–133

    Article  PubMed  CAS  Google Scholar 

  29. Li C, Hu B, Wang X et al (2008) Expression and clinical significance of caspase-3, survivin and k-ras in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi 11(1):90–96

    PubMed  Google Scholar 

  30. Zhu ZH, Yang H, Fu JH et al (2007) Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer. Ai Zheng 26(11):1268–1271

    PubMed  CAS  Google Scholar 

  31. Bria E, Visca P, Novelli F et al (2008) Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer. Eur J Surg Oncol 34(5):593–598

    Article  PubMed  CAS  Google Scholar 

  32. Shinohara ET, Gonzalez A, Massion PP et al (2005) Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 103(8):1685–1692

    Article  PubMed  CAS  Google Scholar 

  33. Kren L, Brazdil J, Hermanova M et al (2004) Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases. Appl Immunohistochem Mol Morphol 12(1):44–49

    Article  PubMed  CAS  Google Scholar 

  34. Ikehara M, Oshita F, Kameda Y et al (2002) Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung. Oncol Rep 9(4):835–838

    PubMed  CAS  Google Scholar 

  35. Wang H, Zheng RH (2006) Expression of cyclin D1 and survivin and their prognostic significance in non-small cell lung cancer. Chin J Clin Med 13(3):386–388

    Google Scholar 

  36. Zhang JR, Yin YM, Liu LK (2010) Correlation of PTEN, PI3K and survivin expression in non small cell lung cancer. Chin Clin Oncol 15(9):789–793

    Google Scholar 

  37. Lv XY, Li QS, Liu CY (2010) The relationship between expression of survivin and its biological characteristic, prognosis in non - small cell lung cancer. J Clin Pulm Med 15(1):5–6

    Google Scholar 

  38. Weng XW, Zhang JH, Ren Z et al (2010) Expression of survivin and correlation between it and prognosis of NSCLC. Chin J Cancer P rev Treat 17(3):198–200

    CAS  Google Scholar 

  39. Wang L, Li X, Zhang X et al (2005) Expression of survivin, microvessel density in non-small cell lung cancer and their correlation with prognosis. J ShanDong Univ 43(6):516–519

    CAS  Google Scholar 

  40. Monzó M, Rosell R, Felip E et al (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17(3):2100–2104

    PubMed  Google Scholar 

  41. Dai CH, Li J, Shi SB et al (2010) Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery. Jpn J Clin Oncol 40(4):327–335

    Article  PubMed  Google Scholar 

  42. Chen P, Li J, Ge LP et al (2010) Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients. Respirology 15(3):501–509

    Article  PubMed  Google Scholar 

  43. Yamashita S, Chujo M, Miyawaki M et al (2009) Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer. J Exp Clin Cancer Res 28:22

    Article  PubMed  Google Scholar 

  44. Karczmarek-Borowska B, Filip A, Wojcierowski J et al (2005) Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study. Folia Histochem Cytobiol 43(4):237–242

    PubMed  CAS  Google Scholar 

  45. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7(12):542–547

    Article  PubMed  CAS  Google Scholar 

  46. Ezponda T, Pajares MJ, Agorreta J et al (2010) The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Clin Cancer Res 16(16):4113–4125

    Article  PubMed  CAS  Google Scholar 

  47. Fan J, Wang L, Jiang GN et al (2008) The role of survivin on overall survival of non-small cell lung cancer, a meta-analysis of published literatures. Lung Cancer 61(1):91–96

    Article  PubMed  Google Scholar 

  48. Earleywine M (1993) The file drawer problem in the meta-analysis of the subjective responses to alcohol. Am J Psychiatry 150(9):1435–1436

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was partly supported by the grants from the Academic Leader Foundation of Anhui Provincial Health Department, Doctor’s Scientific Research Foundation of Bengbu Medical College, National Natural Science Foundation of China (code: 30772532).

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Respiration, First Affiliated Hospital of Bengbu Medical College, Anhui Provincial Key Laboratory of Clinical Basic Research on Respiratory Disease, 227 Chang Huai Road, Bengbu, 233004, Anhui, People’s Republic of China

    Li-nian Huang, Yu-qing Chen, Cheng-ling Zhao, Bei-lei Gong, An-bang Jiang, Wei Jia & Feng-dan Hu

  2. Department of Rheumatology, Anhui Provincial Hospital, Hefei, People’s Republic of China

    Dong-sheng Wang

Authors
  1. Li-nian Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dong-sheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-qing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cheng-ling Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bei-lei Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. An-bang Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wei Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Feng-dan Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Li-nian Huang.

Additional information

Li-nian Huang and Dong-sheng Wang contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, Ln., Wang, Ds., Chen, Yq. et al. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies. Mol Biol Rep 40, 917–924 (2013). https://doi.org/10.1007/s11033-012-2132-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-2132-8

Keywords

Search

Navigation